References
- Belknap BS. Sporotrichosis. Dermatol Clin 1989; 7: 193–202
- Lesher JL, Jr, Fitch M H, Dunlap DB. Subclinical hypothyroidism during potassium iodide therapy for lymphocutaneous sporotrichosis. Cutis 1994; 53: 128–30
- Reshad H, Pegum J S, Keir M IS, et al. Cutaneous lymphatic sporotrichosis treated with ketoconazole—report of an infection acquired in the United Kingdom. Clin Exp Dermatol 1984; 9: 599–603
- Cullen S I, Mauceri A A, Warner N. Successful treatment of disseminated sporotrichosis with ketoconazole. J Am Acad Dermatol 1992; 27: 463–4
- Restrepo A, Robledo J, Gómez I, et al. Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Arch Dermatol 1986; 122: 413–17
- Ebihara T, Sugiura M, Masuda M, et al. Successful treatment of sporotrichosis with itraconazole. J Dermatol Treat 1991; 2: 31–3
- Castro L GM, Belda W, Jr, Cucé LC, et al. Successful treatment of sporotrichosis with oral fluconazole: a report of three cases. Br J Dermatol 1993; 128: 352–6
- Shadomy S, Espinel-Ingroff A, Gebhart RJ. In-vitro studies with SF 86–327, a new orally active allylamine derivative. J Med Vet Mycol 1985; 23: 125–32
- Petranyi G, Meingassner J G, Mieth H. Antifungal activity of the allylamine derivative terbinafine in vitro. Antimicrob Agents Chemother 1987; 31: 1365–8
- Kan V L, Bennett JE. Efficacies of four antifungal agents in experimental murine sporotrichosis. Antimicrob Agents Chemother 1988; 32: 1619–23
- Hull P R, Vismer HF. Treatment of cutaneous sporotrichosis with terbinafine. Br J Dermatol 1992; 126: 51–5, (Suppl 39)